Free Trial
NASDAQ:ICAD

iCAD (ICAD) Stock Price, News & Analysis

iCAD logo
$1.86
+0.01 (+0.54%)
(As of 10/31/2024 ET)

About iCAD Stock (NASDAQ:ICAD)

Key Stats

Today's Range
$1.84
$1.90
50-Day Range
$1.39
$1.96
52-Week Range
$1.18
$2.65
Volume
89,634 shs
Average Volume
163,923 shs
Market Capitalization
$49.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

iCAD Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
8th Percentile Overall Score

ICAD MarketRank™: 

iCAD scored higher than 8% of companies evaluated by MarketBeat, and ranked 654th out of 670 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iCAD is -16.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iCAD is -16.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    iCAD has a P/B Ratio of 1.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about iCAD's valuation and earnings.
  • Percentage of Shares Shorted

    0.94% of the float of iCAD has been sold short.
  • Short Interest Ratio / Days to Cover

    iCAD has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iCAD has recently increased by 8.72%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iCAD does not currently pay a dividend.

  • Dividend Growth

    iCAD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.94% of the float of iCAD has been sold short.
  • Short Interest Ratio / Days to Cover

    iCAD has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iCAD has recently increased by 8.72%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    iCAD has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for iCAD this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for ICAD on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added iCAD to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iCAD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.29% of the stock of iCAD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 24.61% of the stock of iCAD is held by institutions.

  • Read more about iCAD's insider trading history.
Receive ICAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iCAD and its competitors with MarketBeat's FREE daily newsletter.

ICAD Stock News Headlines

ICAD, Inc. (ICAD): A Bull Case Theory
3 US Penny Stocks With Market Caps At Least $40M To Watch
Banking failure dead ahead
If you missed it, my emergency election broadcast is now available - but will be removed soon
Boeing tables 35% pay increase
Icade SA Expects Strong Financial Performance in 2024
ICAD I, Abu Dhabi Emirate
See More Headlines

ICAD Stock Analysis - Frequently Asked Questions

iCAD's stock was trading at $1.77 on January 1st, 2024. Since then, ICAD stock has increased by 5.1% and is now trading at $1.86.
View the best growth stocks for 2024 here
.

iCAD, Inc. (NASDAQ:ICAD) posted its quarterly earnings results on Tuesday, August, 13th. The technology company reported ($0.07) earnings per share for the quarter. The technology company had revenue of $5.03 million for the quarter. iCAD had a negative net margin of 15.67% and a negative trailing twelve-month return on equity of 13.59%.

Top institutional investors of iCAD include Greenwood Capital Associates LLC (1.11%) and Essex LLC (0.52%). Insiders that own company stock include Jonathan Go, Dana R Brown, Andy Sassine, Timothy Norris Irish, Michael S Klein, Charles Ross Carter and Susan Alyson Wood.
View institutional ownership trends
.

Shares of ICAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that iCAD investors own include Enovix (ENVX), Globant (GLOB), Rambus (RMBS), Luminar Technologies (LAZR), Toast (TOST), COMPASS Pathways (CMPS) and Ginkgo Bioworks (DNA).

Company Calendar

Last Earnings
8/13/2024
Today
10/31/2024
Next Earnings (Estimated)
11/11/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ICAD
Employees
67
Year Founded
N/A

Profitability

Net Income
$-4,850,000.00
Pretax Margin
-24.03%

Debt

Sales & Book Value

Annual Sales
$18.80 million
Book Value
$1.27 per share

Miscellaneous

Free Float
23,809,000
Market Cap
$49.36 million
Optionable
Optionable
Beta
1.50

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:ICAD) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners